India Drug Department Seeks Law Ministry Opinion On New Price Caps
This article was originally published in PharmAsia News
India's Department of Pharmaceuticals reportedly has challenged the National Pharmaceutical Pricing Authority's addition of 108 drug formulations subject to price controls.
You may also be interested in...
Agency officials determining needs using existing budgets before requesting more funds and will engage with tech investors for design advice.
Biopharma’s funding support for the Institute for Clinical and Economic Review has been slightly above that of payers and providers for the past three to four years.
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.